Clincosm LogoSign in Get a demo

Small Cell Lung Cancer

Showing 1 - 25 of 254
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, NSCLC, Small Cell Lung Cancer Trial (IMM2520)

Not yet recruiting
  • Advanced Solid Tumor
  • +5 more
  • (no location specified)
Mar 20, 2023

Participation for Small Cell Lung Cancer Patients

Not yet recruiting
  • Small Cell Lung Cancer
    • (no location specified)
    Mar 3, 2023

    Small Cell Lung Cancer Trial (SC0245, Irinotecan)

    Not yet recruiting
    • Small Cell Lung Cancer
    • (no location specified)
    Feb 7, 2023

    Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

    Recruiting
    • Small Cell Lung Cancer
    • Neuroendocrine Carcinoma
    • Chiba, Japan
    • +1 more
    Jan 16, 2023

    Nomogram Predicting Survival in Chinese SCLC Patients

    Completed
    • Small Cell Lung Cancer
    • initial chemotherapy response
    • (no location specified)
    Jan 8, 2023

    Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)

    Not yet recruiting
    • Small Cell Lung Cancer
    • +2 more
    • (no location specified)
    Nov 27, 2022

    TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

    Not yet recruiting
    • Lung Cancer, Non-small Cell
    • Small Cell Lung Cancer
      • (no location specified)
      Nov 16, 2022

      Proteomics in Small Cell Lung Cancer

      Not yet recruiting
      • Small Cell Lung Cancer
        • (no location specified)
        Nov 14, 2022

        Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux

        Not yet recruiting
        • Small Cell Lung Cancer
        • +2 more
        • Association of lurbinectedin and durvalumab
        • Association of carboplatin and etoposide
        • Bordeaux, France
          Institut Bergonié
        Oct 5, 2022

        Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

        Not yet recruiting
        • Cervical Cancer
        • +13 more
        • (no location specified)
        Sep 28, 2022

        Atezolizumab Under Real-World Conditions in Patients Treated in

        Recruiting
        • Urothelial Carcinoma
        • +3 more
        • Buenos Aires, Argentina
        • +314 more
        Aug 22, 2022

        Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

        Recruiting
        • Small Cell Lung Cancer
        • Birmingham, Alabama
        • +32 more
        Aug 18, 2022

        Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

        Recruiting
        • Small Cell Lung Cancer
        • Lung Cancer
        • Aarau, Switzerland
        • +13 more
        Aug 12, 2022

        Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)

        Recruiting
        • Clear Cell Renal Cell Cancer
        • +8 more
        • La Jolla, California
        • +22 more
        Aug 12, 2022

        Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

        Recruiting
        • Microsatellite High Cancers
        • +7 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 8, 2022

        Merkel Cell Carcinoma, Small Cell Lung Cancer Trial in United States (XmAb18087, XmAb18087 ± Pembrolizumab)

        Completed
        • Merkel Cell Carcinoma
        • Small Cell Lung Cancer
        • XmAb18087
        • XmAb18087 ± Pembrolizumab
        • Duarte, California
        • +6 more
        Aug 8, 2022

        NSCLC, Small Cell Lung Cancer Trial in Worldwide (Durvalumab, Cisplatin, Carboplatin)

        Recruiting
        • Non-Small Cell Lung Cancer
        • Small Cell Lung Cancer
        • Tucson, Arizona
        • +20 more
        Aug 3, 2022

        Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)

        Recruiting
        • Small Cell Lung Cancer
        • Pembrolizumab
        • +6 more
        • Gilbert, Arizona
        • +46 more
        Jul 29, 2022

        Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, AMG 404)

        Recruiting
        • Small Cell Lung Cancer
        • Chicago, Illinois
        • +13 more
        Jul 27, 2022

        Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

        Completed
        • Small Cell Lung Cancer
        • +7 more
        • Scottsdale, Arizona
        • +4 more
        Jul 20, 2022

        Small Cell Lung Cancer Trial in Suzhou (Chiauranib)

        Recruiting
        • Small Cell Lung Cancer
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Suzhou University
        Jul 19, 2022

        Small Cell Lung Cancer Trial in Changsha (IBI-322 Plus Lenvatinib)

        Not yet recruiting
        • Small Cell Lung Cancer
        • IBI-322 Plus Lenvatinib
        • Changsha, Hunan, China
          Hunan Cancer hospital
        Jul 14, 2022

        Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

        Recruiting
        • Ovarian Cancer
        • +12 more
        • San Francisco, California
        • +44 more
        Jul 12, 2022

        Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)

        Recruiting
        • Breast Cancer
        • +12 more
        • Checkpoint Blockade, Immune
        • Brussel, Anderlecht, Belgium
          Institut Jules Bordet
        Jul 1, 2022

        Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

        Recruiting
        • Small Cell Lung Cancer
        • atezolizumab
        • Chalon-sur-Saône, France
        • +1 more
        Jun 29, 2022